BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 15173106)

  • 1. The small leucine-rich proteoglycan biglycan modulates BMP-4-induced osteoblast differentiation.
    Chen XD; Fisher LW; Robey PG; Young MF
    FASEB J; 2004 Jun; 18(9):948-58. PubMed ID: 15173106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissection of the sets of genes that control the behavior of biglycan-deficient pre-osteoblasts using oligonucleotide microarrays.
    Chen XD; Bian X; Teslovich TM; Stephan DA; Young MF
    Bone; 2005 Aug; 37(2):192-203. PubMed ID: 15922682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biglycan modulates osteoblast differentiation and matrix mineralization.
    Parisuthiman D; Mochida Y; Duarte WR; Yamauchi M
    J Bone Miner Res; 2005 Oct; 20(10):1878-86. PubMed ID: 16160746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycosaminoglycan chains of biglycan promote bone morphogenetic protein-4-induced osteoblast differentiation.
    Ye Y; Hu W; Guo F; Zhang W; Wang J; Chen A
    Int J Mol Med; 2012 Nov; 30(5):1075-80. PubMed ID: 22895561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biglycan deficiency increases osteoclast differentiation and activity due to defective osteoblasts.
    Bi Y; Nielsen KL; Kilts TM; Yoon A; A Karsdal M; Wimer HF; Greenfield EM; Heegaard AM; Young MF
    Bone; 2006 Jun; 38(6):778-86. PubMed ID: 16364709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in secreted and cell associated proteoglycan synthesis during conversion of myoblasts to osteoblasts in response to bone morphogenetic protein-2: role of decorin in cell response to BMP-2.
    Gutierrez J; Osses N; Brandan E
    J Cell Physiol; 2006 Jan; 206(1):58-67. PubMed ID: 15920756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tensile stress induces bone morphogenetic protein 4 in preosteoblastic and fibroblastic cells, which later differentiate into osteoblasts leading to osteogenesis in the mouse calvariae in organ culture.
    Ikegame M; Ishibashi O; Yoshizawa T; Shimomura J; Komori T; Ozawa H; Kawashima H
    J Bone Miner Res; 2001 Jan; 16(1):24-32. PubMed ID: 11149486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor beta1 in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation.
    Lee MH; Javed A; Kim HJ; Shin HI; Gutierrez S; Choi JY; Rosen V; Stein JL; van Wijnen AJ; Stein GS; Lian JB; Ryoo HM
    J Cell Biochem; 1999 Apr; 73(1):114-25. PubMed ID: 10088730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Harmine promotes osteoblast differentiation through bone morphogenetic protein signaling.
    Yonezawa T; Lee JW; Hibino A; Asai M; Hojo H; Cha BY; Teruya T; Nagai K; Chung UI; Yagasaki K; Woo JT
    Biochem Biophys Res Commun; 2011 Jun; 409(2):260-5. PubMed ID: 21570953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multilineage differentiation of Cbfa1-deficient calvarial cells in vitro.
    Kobayashi H; Gao Yh; Ueta C; Yamaguchi A; Komori T
    Biochem Biophys Res Commun; 2000 Jul; 273(2):630-6. PubMed ID: 10873656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biglycan deficiency interferes with ovariectomy-induced bone loss.
    Nielsen KL; Allen MR; Bloomfield SA; Andersen TL; Chen XD; Poulsen HS; Young MF; Heegaard AM
    J Bone Miner Res; 2003 Dec; 18(12):2152-8. PubMed ID: 14672350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone morphogenetic proteins, extracellular matrix, and mitogen-activated protein kinase signaling pathways are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells.
    Xiao G; Gopalakrishnan R; Jiang D; Reith E; Benson MD; Franceschi RT
    J Bone Miner Res; 2002 Jan; 17(1):101-10. PubMed ID: 11771655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation of human marrow stromal precursor cells: bone morphogenetic protein-2 increases OSF2/CBFA1, enhances osteoblast commitment, and inhibits late adipocyte maturation.
    Gori F; Thomas T; Hicok KC; Spelsberg TC; Riggs BL
    J Bone Miner Res; 1999 Sep; 14(9):1522-35. PubMed ID: 10469280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone morphogenetic protein-2 restores mineralization in glucocorticoid-inhibited MC3T3-E1 osteoblast cultures.
    Luppen CA; Smith E; Spevak L; Boskey AL; Frenkel B
    J Bone Miner Res; 2003 Jul; 18(7):1186-97. PubMed ID: 12854828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and characterization of a mesenchymal cell line that differentiates into osteoblasts in response to BMP-2 from calvariae of GFP transgenic mice.
    Kadowaki A; Tsukazaki T; Hirata K; Shibata Y; Okubo Y; Bessho K; Komori T; Yoshida N; Yamaguchi A
    Bone; 2004 Jun; 34(6):993-1003. PubMed ID: 15193545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted disruption of two small leucine-rich proteoglycans, biglycan and decorin, excerpts divergent effects on enamel and dentin formation.
    Goldberg M; Septier D; Rapoport O; Iozzo RV; Young MF; Ameye LG
    Calcif Tissue Int; 2005 Nov; 77(5):297-310. PubMed ID: 16283572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-related osteoporosis in biglycan-deficient mice is related to defects in bone marrow stromal cells.
    Chen XD; Shi S; Xu T; Robey PG; Young MF
    J Bone Miner Res; 2002 Feb; 17(2):331-40. PubMed ID: 11811564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of bone matrix protein expression and induction of differentiation of human osteoblasts and human bone marrow stromal cells by bone morphogenetic protein-2.
    Lecanda F; Avioli LV; Cheng SL
    J Cell Biochem; 1997 Dec; 67(3):386-96. PubMed ID: 9361193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic effects of biglycan deficiency are linked to collagen fibril abnormalities, are synergized by decorin deficiency, and mimic Ehlers-Danlos-like changes in bone and other connective tissues.
    Corsi A; Xu T; Chen XD; Boyde A; Liang J; Mankani M; Sommer B; Iozzo RV; Eichstetter I; Robey PG; Bianco P; Young MF
    J Bone Miner Res; 2002 Jul; 17(7):1180-9. PubMed ID: 12102052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone morphogenetic protein regulation of forkhead/winged helix transcription factor Foxc2 (Mfh1) in a murine mesodermal cell line C1 and in skeletal precursor cells.
    Nifuji A; Miura N; Kato N; Kellermann O; Noda M
    J Bone Miner Res; 2001 Oct; 16(10):1765-71. PubMed ID: 11585339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.